news APOBEC3B genetic mutation signatures could be used to target cancers 10 February 2020 | By Hannah Balfour (Drug Target Review) An innovative new vaccine technique, which sensitises the immune system to the genetic signature of APOBEC mutations (often found in cancers), increases the efficacy of immunotherapies.
news Innovative probe visualises tumours 8 December 2017 | By Drug Target Review A new probe has the potential to help surgeons visualise primary non-fluorescing, low-grade gliomas during surgery to remove the tumour.
news New weakness found in most common childhood malignant brain tumour 7 December 2017 | By Drug Target Review A new weakness found in medulloblastoma could lead to more personalised medicine and improved treatment for some patients.
news Starving a childhood brain tumour of glutamine, may improve the effect of chemotherapy 1 November 2017 | By Dr Zara Kassam (Drug Target Review) Researchers have shown that starving a childhood brain tumour of the amino acid glutamine may improve the effect of chemotherapy...
news US Phase 2 trial to test targeted drugs in paediatric tumours 25 July 2017 | By Dr Zara Kassam (Drug Target Review) Phase 2 trial to explore targeted therapies for children with solid tumours that harbour specific genetic mutations which have progressed during or after standard therapy...